These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2299799

  • 21. Randomized study of darbepoetin alfa and recombinant human erythropoietin for treatment of renal anemia in chronic renal failure patients receiving peritoneal dialysis.
    Li WY, Chu TS, Huang JW, Wu MS, Wu KD.
    J Formos Med Assoc; 2008 Nov; 107(11):843-50. PubMed ID: 18971153
    [Abstract] [Full Text] [Related]

  • 22. Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.
    Radermacher J, Koch KM.
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S56-60. PubMed ID: 8608665
    [Abstract] [Full Text] [Related]

  • 23. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group.
    Kulzer P, Schaefer RM, Krahn R, Schaefer L, Heidland A.
    Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Prata MM, de Sousa FT, Barbas JV, da Costa AM, Vinhas J, Moreira P, Abrantes C, Lopes MC.
    Acta Med Port; 1990 Apr; 3(3):149-53. PubMed ID: 2220424
    [Abstract] [Full Text] [Related]

  • 26. Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. The US Recombinant Human Erythropoietin Predialysis Study Group.
    Am J Kidney Dis; 1991 Jul; 18(1):50-9. PubMed ID: 2063855
    [Abstract] [Full Text] [Related]

  • 27. Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.
    Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL.
    Am J Kidney Dis; 1995 Apr; 25(4):548-54. PubMed ID: 7702049
    [Abstract] [Full Text] [Related]

  • 28. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin.
    Schaefer RM, Kokot F, Kuerner B, Zech M, Heidland A.
    Int J Artif Organs; 1989 Jul; 12(7):445-9. PubMed ID: 2767790
    [Abstract] [Full Text] [Related]

  • 29. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
    Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS.
    Ann Intern Med; 1992 Nov 01; 117(9):739-48. PubMed ID: 1416576
    [Abstract] [Full Text] [Related]

  • 30. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
    Roger SD, Baker LR, Raine AE.
    Clin Nephrol; 1993 Feb 01; 39(2):103-10. PubMed ID: 8448912
    [Abstract] [Full Text] [Related]

  • 31. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R.
    Semin Nephrol; 1989 Mar 01; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [Abstract] [Full Text] [Related]

  • 32. Clinical effect of recombinant human erythropoietin on anemia associated with chronic renal failure. A multi-institutional study in Japan.
    Akizawa T, Koshikawa S, Takaku F, Urabe A, Akiyama N, Mimura N, Otsubo O, Nihei H, Suzuki Y, Kawaguchi Y.
    Int J Artif Organs; 1988 Sep 01; 11(5):343-50. PubMed ID: 3056862
    [Abstract] [Full Text] [Related]

  • 33. Effectiveness and safety of recombinant human erythropoietin in predialysis patients. Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients.
    Nephron; 1992 Sep 01; 61(4):399-403. PubMed ID: 1501735
    [Abstract] [Full Text] [Related]

  • 34. Recombinant human erythropoietin treatment in pre-dialysis patients. A double-blind placebo-controlled trial.
    Lim VS, DeGowin RL, Zavala D, Kirchner PT, Abels R, Perry P, Fangman J.
    Ann Intern Med; 1989 Jan 15; 110(2):108-14. PubMed ID: 2909202
    [Abstract] [Full Text] [Related]

  • 35. Benefits and concerns of treating pre-dialysis and renal transplant patients with recombinant human erythropoietin.
    Vanrenterghem Y, Vanwalleghem J.
    Nephrol Dial Transplant; 1998 Jan 15; 13 Suppl 2():13-5. PubMed ID: 9566485
    [Abstract] [Full Text] [Related]

  • 36. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients.
    Delano BG.
    Am J Kidney Dis; 1989 Aug 15; 14(2 Suppl 1):14-8. PubMed ID: 2757025
    [Abstract] [Full Text] [Related]

  • 37. [Effect of recombinant human erythropoietin on renal function in predialysis patients].
    Tsubakihara Y, Itoh T, Kitamura E, Okada N, Nakanishi I, Iida N.
    Nihon Jinzo Gakkai Shi; 1991 Jun 15; 33(6):557-63. PubMed ID: 1920935
    [Abstract] [Full Text] [Related]

  • 38. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C, Blumberg A.
    Clin Nephrol; 1989 Feb 15; 31(2):55-9. PubMed ID: 2920469
    [Abstract] [Full Text] [Related]

  • 39. Outcome of renal transplantation in patients treated with erythropoietin.
    Linde T, Wahlberg J, Wikström B, Danielson BG.
    Clin Nephrol; 1992 May 15; 37(5):260-3. PubMed ID: 1606776
    [Abstract] [Full Text] [Related]

  • 40. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin.
    Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW.
    N Engl J Med; 1989 Jul 20; 321(3):158-63. PubMed ID: 2747747
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.